Elan News

Irish biotech group Elan and its US partner Biogen Idec have won US clearance to modify the label of their multiple-sclerosis shot Tysabri with new safety information that may double the treatment's worldwide sales.

Investors dumped stocks today, forcing a retreat from a five-month high on European equity markets, amid fears that the euro zone debt crisis will make it harder for sovereigns and banks to raise necessary capital this year.

Sport equipment group Elan is to end the year with EUR 500,000 in operating profit, a U-turn from last year's operating loss of EUR 800,000 and above the company plans, the supervisory board of the Begunje-based company said on Tuesday.The group's projections show that Elan... Sport equipment group Elan is to end the year with EUR 500,000 in ... (more)